# Safety and Efficacy of Edoxaban in Thoracoscopic Ablation

> **NCT04121767** · NA · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Atrial Fibrillation
- Anticoagulants and Bleeding Disorders

## Interventions

- **DRUG:** Edoxaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT04121767
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-07-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04121767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04121767, "Safety and Efficacy of Edoxaban in Thoracoscopic Ablation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04121767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*